In vitro susceptibility of Neisseria meningitidis

Jennifer M. Andrews* and Richard Wise

Department of Microbiology, City Hospital Trust, Birmingham B18 7QH, UK

Sir,

Reduced susceptibility of Neisseria meningitidis to penicillin (MICs >= 0.12 mg/L) in the UK was reported by Jones & Sutcliffe1 in 1990 to be at a level of 3%, comparable to that found in 1987. We have recently undertaken an in vitro study to investigate the susceptibility of meningococci from our collection of strains, to a variety of antimicrobial agents, including penicillin, using BSAC methodology.2 During this investigation we detected a ß-lactamasenegative strain with penicillin and amoxycillin MICs of 0.12 mg/L and 0.25 mg/L, respectively.

In 1998 the Working Party on Sensitivity Testing published, in the BSAC Summer Newsletter, recommendations for the testing and interpretation of the sensitivity of meningococci to penicillin. We therefore decided to see whether, using these recommendations, we would be able to identify this ß-lactamase-negative strain as having reduced susceptibility to penicillin. As can be seen in the FigureGo, 55 strains with penicillin MICs of <=0.06 mg/L gave corresponding zones of inhibition with a 1 U penicillin disc of >=26 mm, unlike the strain with reduced susceptibility which had a zone of 22 mm. Using BSAC interpretative criteria (zone diameter breakpoint denoting sensitivity >=20 mm) this strain would be regarded as sensitive to penicillin. Given that 3% of infections may be caused by meningococci with reduced susceptibility to penicillin and the clinical evidence that infections caused by these strains may not respond to standard dosing regimens,3 the necessity for detecting these strains is apparent. These data suggest that the zone diameter breakpoint for determining sensitivity of meningococci to penicillin, using BSAC methodology and a 1 U penicillin disc should be amended so that a zone of >=25 mm denotes sensitivity.



View larger version (20K):
[in this window]
[in a new window]
 
Figure. Zone diameter distribution (mm) for meningococci using BSAC disc testing methodology using a 1 U penicillin disc.

 

Notes

J Antimicrob Chemother 2000;45: 548–549

* Corresponding author. Tel: +44-121-507-5693; Fax: +44-121-551-7763. Back

References

1 . Jones, D. M. & Sutcliffe, E. M. (1990). Meningococci with reduced susceptibility to penicillin. Lancet 335, 863–4.[ISI][Medline]

2 . Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1–50.[ISI][Medline]

3 . Turner, P. C., Southern, K. W., Spencer, N. J. & Pullen, H. (1990). Treatment failure in meningococcal meningitis. Lancet 335, 732–3.[ISI][Medline]





This Article
Extract
FREE Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Disclaimer
Request Permissions
Google Scholar
Articles by Andrews, J. M.
Articles by Wise, R.
PubMed
PubMed Citation
Articles by Andrews, J. M.
Articles by Wise, R.